Genomics

Dataset Information

152

Epigenetic regulation of the apoptosis program in t(8;21) AMLs by an AML1-ETO, ERG and RUNX1 triad


ABSTRACT: The t(8;21) acute myeloid leukemia associated oncoprotein AML1-ETO is a transcription factor that aberrantly regulates the pathways that lead to myeloid differentiation. Here, we set out to investigate the effects of AML1-ETO on gene expression and the epigenome in patient blast cells. We identify two modules, one in which AML1-ETO binds promoter regions of active genes and one represented by non-promoter binding to accessible, yet inactive chromatin regions. Using genome-wide binding analysis and mass spectrometry interaction studies we identify ERG, FLI1, TAL1 and RUNX1 as common binding factors of all AML1-ETO occupied genomic regions, while LYL1 and LMO2 show preferential binding in the context of non promoter regions. Epigenetically, reduced histone acetylation levels at non-promoter regions seems HDAC dependent, as treatment with an HDACi increases acetylation and induces cell death. Both AML1-ETO modules are represented in most aberrantly regulated pathways, including many signaling pathways, self-renewal and apoptosis. For the latter, the expression of the wild type transcription factors RUNX1 and ERG is required, as alterations in expression are associated with the onset of an apoptosis program. Interestingly, upon RUNX1 or ERG knockdown this onset seems to be dependent on increased AML1-ETO expression as combinatorial knockdown of RUNX1/AML1-ETO or ERG/AML1-ETO results in rescue from apoptosis. Together our results show that the balanced interplay of the epigenetic environment and transcription factors retains an anti apoptotic phenotype in t(8;21) AML cells. Overall design: 14 samples for ChIP seq and 2 RNA-seq samples

INSTRUMENT(S): Illumina Genome Analyzer IIx (Homo sapiens)

SUBMITTER: Joost Martens 

PROVIDER: GSE76464 | GEO | 2016-11-15

SECONDARY ACCESSION(S): PRJNA307457

REPOSITORIES: GEO

altmetric image

Publications


The t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hematopoietic differentiation. Here, we have investigated its effects on the transcriptome and epigenome in t(8,21) patient cells. AML1-ETO binding was found at promoter regions of active genes with high levels of histone acetylation but also at distal elements characterized by low acetylation levels and binding of the hematopoietic transcription factors LYL1 and LMO2. In contrast, ERG, FLI1, TAL1, and RUNX1  ...[more]

Similar Datasets

2013-08-18 | E-GEOD-45743 | ArrayExpress
2013-08-18 | E-GEOD-45738 | ArrayExpress
| GSE80508 | GEO
2008-11-28 | GSE10578 | GEO
2012-03-28 | GSE29222 | GEO
| GSE23730 | GEO
2008-11-27 | E-GEOD-10578 | ArrayExpress
2012-03-27 | E-GEOD-29222 | ArrayExpress
2012-03-26 | E-GEOD-29225 | ArrayExpress
2012-09-18 | E-GEOD-23730 | ArrayExpress